ASTH
Astrana Health, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Buy
+44/100
Last price
37.00
▲ 0.19 (0.52%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
36.81
Day high
37.70
Day low
36.81
Volume
227.13K
Market cap
$1.84B
P/E (TTM)
44.58
52W range
18.08 – 51.60
Trailing performance
Returnvs SPY
1W
+4.37%
+2.4%
1M
-3.82%
-5.0%
3M
-20.05%
-24.6%
6M
+33.33%
+15.1%
YTD
+49.13%
+34.9%
1Y
+28.70%
+12.3%
3Y
+19.94%
-62.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ASTH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
11.67M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | SCHMIDT DAVID Director |
CONVERSION | 20.00K | $100.00K | Direct |
| Jun 10, 26 | KITAYAMA MITCHELL W Director |
STOCK | 4.99K | $0 | Direct |
| Jun 10, 26 | DAI WEILI Director |
STOCK | 4.53K | $0 | Direct |
| Jun 10, 26 | SCHMIDT DAVID Director |
STOCK | 4.53K | $0 | Direct |
| Jun 10, 26 | CHIANG JOHN Director |
STOCK | 4.53K | $0 | Direct |
| Jun 10, 26 | MAZDYASNI MATTHEW Director |
STOCK | 4.53K | $0 | Direct |
| Jun 10, 26 | DONG LINDA Director |
STOCK | 4.53K | $0 | Direct |
| Apr 6, 26 | LAM THOMAS S Director |
STOCK | 41.67K | $0 | Direct |
| Apr 6, 26 | SIM KENNETH T Officer and Director |
STOCK | 100.00K | $0 | Direct |
| Apr 6, 26 | SIM BRANDON Chief Executive Officer |
STOCK | 201.06K | $0 | Direct |
| Apr 1, 26 | KUMAR DINESH M Officer |
STOCK | 35.30K | $0 | Direct |
| Feb 2, 26 | SIM BRANDON Chief Executive Officer |
CONVERSION | 21.33K | $495.80K | Direct |
| Jan 13, 26 | SCHMIDT DAVID Director |
CONVERSION | 20.00K | $115.80K | Direct |
| Dec 8, 25 | LAM THOMAS S Director |
CONVERSION | 29.50K | $524.55K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BASHO CHANDAN |
Chief Operating Officer | 192.75K | Stock Award(Grant) |
CHIANG JOHN |
Director | 35.37K | Stock Award(Grant) |
DONG LINDA |
Director | 97.13K | Stock Award(Grant) |
KUMAR DINESH M |
Officer | 177.66K | Stock Award(Grant) |
LAM THOMAS S |
Director | 7.73M | Stock Award(Grant) |
MARSH LINDA |
Director | 92.61K | Conversion of Exercise of derivative security |
MAZDYASNI MATTHEW |
Director | 39.29K | Stock Award(Grant) |
SCHMIDT DAVID |
Director | 36.02K | Conversion of Exercise of derivative security |
SIM BRANDON |
Chief Executive Officer | 1.90M | Stock Award(Grant) |
SIM KENNETH T |
Officer and Director | 7.69M | Stock Award(Grant) |
Fundamentals
Market cap$1.84B
Enterprise value$2.24B
Revenue (TTM)$3.84B
Gross profit$402.00M
EBITDA$174.91M
Net income$40.55M
EPS (TTM)$0.83
Free cash flow$231.19M
Total cash$400.79M
Total debt$979.41M
Book value / share$16.87
Shares outstanding49.60M
Float38.83M
Short % of float12.57%
Dividend yield0.00%
Beta (5Y)1.03
Valuation & profitability ratios
Trailing P/E44.58
Forward P/E10.17
PEG ratio—
Price / sales—
Price / book2.19
EV / revenue0.58
EV / EBITDA12.81
Gross margin10.46%
Operating margin3.53%
Profit margin1.05%
Return on equity6.90%
Return on assets3.76%
Debt / equity163.62
Current ratio1.23
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.18B | $2.03B | $1.39B | $1.14B | +56.4% |
| Operating revenue | $3.15B | $2.02B | $1.38B | $1.14B | +56.2% |
| Cost of revenue | $2.84B | $1.76B | $1.17B | $944.68M | +61.1% |
| Gross profit | $341.53M | $271.39M | $214.96M | $199.48M | +25.8% |
| Selling, general & admin | $217.26M | $154.11M | $112.60M | $77.67M | +41.0% |
| Total operating expense | $263.00M | $182.04M | $130.34M | $95.21M | +44.5% |
| Operating income | $78.53M | $89.35M | $84.61M | $104.27M | -12.1% |
| Net interest income | -$37.77M | -$18.59M | -$1.89M | -$5.94M | -103.2% |
| Pre-tax income | $39.61M | $80.82M | $89.84M | $86.62M | -51.0% |
| Tax provision | $15.53M | $30.89M | $31.99M | $40.88M | -49.7% |
| Net income | $22.49M | $43.15M | $60.72M | $45.17M | -47.9% |
| Net income to common | $22.49M | $43.15M | $60.72M | $45.17M | -47.9% |
| Basic EPS | 0.46 | 0.91 | 1.30 | 1.09 | -49.5% |
| Diluted EPS | 0.46 | 0.90 | 1.29 | 1.08 | -48.9% |
| EBIT | $89.53M | $113.92M | $105.94M | $94.54M | -21.4% |
| EBITDA | $135.28M | $141.84M | $123.69M | $112.08M | -4.6% |
| Basic shares | 49.08M | 47.42M | 46.71M | 45.00M | +3.5% |
| Diluted shares | 49.37M | 47.94M | 47.07M | 45.42M | +3.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $429.47M | $288.45M | $293.81M | $288.03M | — | +48.9% |
| Cash & short-term investments | $429.47M | $288.45M | $296.31M | $293.59M | — | +48.9% |
| Accounts receivable | $374.46M | $275.99M | $76.78M | $49.63M | — | +35.7% |
| Total current assets | $863.31M | $638.50M | $461.51M | $428.13M | — | +35.2% |
| Property, plant & equipment | $93.07M | $46.88M | $44.57M | $128.98M | — | +98.5% |
| Goodwill & intangibles | $1.14B | $537.43M | $350.48M | $345.91M | — | +111.4% |
| Total assets | $2.22B | $1.35B | $933.36M | $966.21M | — | +63.8% |
| Total current liabilities | $615.27M | $365.61M | $218.67M | $148.61M | — | +68.3% |
| Current debt | $47.87M | $9.38M | $19.50M | $619.00K | — | +410.6% |
| Long-term debt | $990.90M | $425.30M | $258.94M | $203.39M | — | +133.0% |
| Total debt | $1.08B | $470.68M | $321.01M | $229.36M | — | +129.1% |
| Total liabilities | $1.66B | $840.73M | $522.59M | $407.67M | — | +97.5% |
| Retained earnings | $308.38M | $286.28M | $243.13M | $182.42M | — | +7.7% |
| Shareholder equity | — | — | — | $542.56M | $448.17M | — |
| Working capital | $248.04M | $272.89M | $242.83M | $279.51M | — | -9.1% |
| Net tangible assets | -$356.98M | $175.29M | $263.74M | $196.65M | — | -303.7% |
| Shares issued | 59.46M | 58.53M | 57.43M | 56.87M | — | +1.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $24.08M | $49.93M | $57.85M | $45.74M | -51.8% |
| Depreciation & amortisation | $45.75M | $27.93M | $17.75M | $17.54M | +63.8% |
| Stock-based compensation | $38.60M | $34.54M | $22.04M | $16.10M | +11.8% |
| Change in working capital | -$3.10M | -$63.61M | -$23.39M | -$1.96M | +95.1% |
| Operating cash flow | $114.60M | $52.20M | $68.23M | $82.13M | +119.5% |
| Capital expenditure | -$10.11M | -$8.03M | -$28.53M | -$22.94M | -25.8% |
| Investing cash flow | -$539.00M | -$192.40M | -$65.52M | -$7.11M | -180.2% |
| Share buybacks | -$15.43M | -$937.00K | -$10.19M | -$9.25M | -1,546.6% |
| Dividends paid | -$7.88M | -$4.04M | -$62.07M | -$14.03M | -95.4% |
| Financing cash flow | $569.35M | $135.15M | $3.42M | -$20.09M | +321.3% |
| Free cash flow | $104.49M | $44.17M | $39.70M | $59.19M | +136.6% |
| End cash position | $434.05M | $289.10M | $294.15M | $288.03M | +50.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $972.52M | $965.10M | $950.53M | $956.05M | $654.81M | +0.8% |
| Operating revenue | $963.81M | $958.91M | $938.40M | $949.48M | $649.97M | +0.5% |
| Cost of revenue | $868.50M | $859.36M | $855.48M | $858.86M | $576.84M | +1.1% |
| Gross profit | $104.02M | $105.74M | $95.04M | $97.19M | $77.97M | -1.6% |
| Selling, general & admin | $54.15M | $61.74M | $60.25M | $62.39M | $50.73M | -12.3% |
| Total operating expense | $69.70M | $77.22M | $76.65M | $77.98M | $57.63M | -9.7% |
| Operating income | $34.32M | $28.53M | $18.39M | $19.21M | $20.34M | +20.3% |
| Net interest income | -$10.09M | -$12.29M | -$13.53M | -$14.20M | -$5.05M | +17.9% |
| Pre-tax income | $27.21M | $19.71M | $7.51M | $5.67M | $16.82M | +38.1% |
| Tax provision | $8.76M | $6.58M | $944.00K | $4.59M | $6.61M | +33.1% |
| Net income | $19.74M | $14.44M | $6.00M | $373.00K | $9.42M | +36.7% |
| Net income to common | $19.74M | $14.44M | $6.00M | $373.00K | $9.42M | +36.7% |
| Basic EPS | 0.40 | 0.30 | 0.12 | 0.01 | 0.19 | +33.3% |
| Diluted EPS | 0.40 | 0.29 | 0.12 | 0.01 | 0.19 | +37.9% |
| EBIT | $43.21M | $35.81M | $25.03M | $23.39M | $24.21M | +20.7% |
| EBITDA | $58.76M | $51.29M | $41.43M | $38.98M | $31.11M | +14.6% |
| Basic shares | 49.12M | 48.85M | 49.23M | 37.30M | 49.19M | +0.5% |
| Diluted shares | 49.78M | 49.05M | 49.53M | 37.30M | 49.47M | +1.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $400.79M | $478.38M | $429.47M | $462.23M | $339.70M | -16.2% |
| Cash & short-term investments | $400.79M | $478.38M | $429.47M | $463.45M | $342.12M | -16.2% |
| Accounts receivable | $465.08M | $467.39M | $374.46M | $381.21M | $348.73M | -0.5% |
| Total current assets | $919.16M | $1.00B | $863.31M | $883.63M | $729.15M | -8.5% |
| Property, plant & equipment | $101.76M | $93.48M | $93.07M | $90.10M | $48.43M | +8.9% |
| Goodwill & intangibles | $1.13B | $1.13B | $1.14B | $1.15B | $522.65M | -0.1% |
| Total assets | $2.28B | $2.36B | $2.22B | $2.24B | $1.44B | -3.3% |
| Total current liabilities | $747.64M | $745.37M | $615.27M | $629.93M | $459.75M | +0.3% |
| Current debt | $53.85M | $47.87M | $47.87M | $47.87M | $12.50M | +12.5% |
| Long-term debt | $882.65M | $979.76M | $990.90M | $1.00B | $401.06M | -9.9% |
| Total debt | $979.41M | $1.07B | $1.08B | $1.09B | $447.59M | -8.1% |
| Total liabilities | $1.68B | $1.78B | $1.66B | $1.68B | $904.40M | -5.5% |
| Retained earnings | $342.36M | $322.71M | $308.38M | $302.49M | $302.21M | +6.1% |
| Shareholder equity | $830.22M | $800.27M | $779.29M | $775.54M | $765.46M | +3.7% |
| Working capital | $171.52M | $258.73M | $248.04M | $253.70M | $269.41M | -33.7% |
| Net tangible assets | -$300.08M | -$331.65M | -$356.98M | -$372.78M | $242.81M | +9.5% |
| Shares issued | 49.23M | 59.64M | 59.46M | 59.32M | 59.04M | -17.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $18.45M | $13.13M | $6.56M | $1.08M | $10.22M | — | +40.5% |
| Depreciation & amortisation | $15.55M | $15.48M | $16.40M | $15.60M | $6.90M | — | +0.5% |
| Stock-based compensation | $11.79M | $9.89M | $11.38M | $7.70M | $11.71M | — | +19.1% |
| Change in working capital | -$5.00M | $23.92M | -$39.22M | -$15.45M | $58.85M | — | -120.9% |
| Operating cash flow | $32.75M | $68.06M | -$2.89M | $9.96M | $90.90M | — | -51.9% |
| Capital expenditure | -$3.88M | -$4.00M | -$3.06M | -$2.55M | -$1.42M | — | +3.1% |
| Investing cash flow | -$6.23M | -$2.84M | -$1.06M | -$534.47M | -$1.08M | — | -119.0% |
| Share buybacks | $100.00K | -$2.91M | — | — | $0 | $0 | +103.4% |
| Dividends paid | -$95.00K | -$104.00K | -$1.56M | -$96.00K | -$778.00K | — | +8.7% |
| Financing cash flow | -$104.07M | -$15.96M | -$26.34M | $648.49M | -$8.64M | — | -552.1% |
| Free cash flow | $28.87M | $64.06M | -$5.95M | $7.40M | $89.48M | — | -54.9% |
| End cash position | $405.74M | $483.30M | $434.05M | $464.33M | $340.35M | — | -16.0% |
Options analytics
Put / call volume
1.63
Put-heavy session
Put / call open interest
0.01
Positioning, not flow
Max pain
35.00
-5.4% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
8
Contracts, this expiry
Put volume
13
Contracts, this expiry
Heaviest call OI
40.00
4.12K contracts
Heaviest put OI
35.00
24 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.73 | 0.80 | +9.6% |
| Mar 2026 | 0.65 | 0.74 | +13.9% |
| Dec 2025 | 0.33 | 0.42 | +28.6% |
| Sep 2025 | 0.61 | 0.67 | +10.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.88 | 3 | $1.02B | +6.7% |
| Next quarter | 0.65 | 3 | $1.02B | +7.8% |
| Current year | 3.07 | 3 | $3.98B | +25.2% |
| Next year | 3.64 | 3 | $4.38B | +10.1% |
Analyst targets & ownership
Mean target$51.67
High target$65.00
Low target$41.00
Implied upside39.64%
Analyst count9
ConsensusSTRONG BUY
Strong buy / Buy2 / 7
Hold1
Sell / Strong sell0 / 0
Held by insiders22.81%
Held by institutions66.19%
Institutions holding299
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
35.59
+3.96% from price
SMA 20
36.15
+2.36% from price
SMA 50
37.00
-0.00% from price
SMA 100
39.29
-5.82% from price
SMA 200
32.82
+12.73% from price
EMA 12
35.99
+2.80% from price
EMA 26
36.49
+1.39% from price
EMA 50
37.30
-0.79% from price
RSI (14)
52.2
Neutral
MACD (12,26,9)
-0.50
Hist 0.26
ATR (14)
1.84
4.97% of price
Realised vol 30D
44.1%
Annualised
Bollinger upper
39.46
20, 2σ
Bollinger lower
32.83
20, 2σ
50 / 200 cross
Golden
37.00 vs 32.82
Trend bias
Above 200
+12.73%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.63
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
44.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-46.4%
Peak to trough
Max drawdown 5Y
-84.8%
Peak to trough
ATR 14
1.84
4.97% of price
Beta (reported)
1.03
5Y monthly, from filing
Short interest
Shares short
3.27M
Prior 3.18M
Change vs prior
+2.8%
Shorts adding
% of float
12.57%
Elevated
% of shares out
6.60%
Against total outstanding
Days to cover
10.5
Crowded exit
Float
38.83M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 26 | Freedom Capital Markets | MAINTAINED | Buy | Buy |
| Sep 15, 26 | Oppenheimer | INITIATED | — | Outperform |
| Aug 11, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 14, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 14, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 2, 26 | BTIG | MAINTAINED | Buy | Buy |
| May 26, 26 | Barclays | UPGRADE | Equal-Weight | Overweight |
| May 14, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| May 12, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| May 11, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| May 8, 26 | BTIG | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:10
Split dateApr 27, 2015
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-23
Corporate Changes & Voting Matters
8-K · 2026-09-15
Periodic Financial Reports
10-Q · 2026-08-10
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-13
Corporate Changes & Voting Matters
8-K · 2026-07-01
Offering Registrations
S-8 · 2026-06-11
Corporate Changes & Voting Matters
8-K · 2026-06-10
Headlines
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
StockStory · 7d ago
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · 14d ago
Why Astrana Health (ASTH) Shares Are Trading Lower Today
StockStory · 14d ago
Sector Update: Healthcare Stocks Retreat in Afternoon Trading
MT Newswires · 14d ago
Sector Update: Healthcare
MT Newswires · 14d ago
Astrana Health Reports Material Cyberattack; Shares Fall Pre-Bell
MT Newswires · 14d ago
Sector Update: Healthcare Stocks Rise Thursday Afternoon
MT Newswires · 20d ago
Astrana Health Shares Fall After GlassHouse Research Publishes Short-Seller Report
MT Newswires · 20d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.